超声心动图联合全身免疫炎症指数对心力竭衰早期诊断的研究进展
Research Progress on the Application of Echocardiography Combined with Systemic Immune Inflammation Index in the Early Diagnosis of Heart Failure
DOI: 10.12677/acm.2024.14113038, PDF,   
作者: 顾杨洋:重庆医科大学第二临床学院,重庆;罗 朋*:重庆医科大学附属第二医院超声科,重庆
关键词: 超声心动图全身免疫炎症指数心衰综述Echocardiography Systemic Immune-Inflammation Index Heart Failure Review
摘要: 心力衰竭是心血管疾病最主要的死亡原因。C期(症状性心衰期)、D期(晚期心衰)患者面临着死亡率高、反复住院、治疗效果差等问题,故早诊断、早干预对有效延缓或预防心衰的发生、发展有着重要意义。目前,超声心动图仍是心衰患者首选的心脏影像学检查方法。而在实验室检查方面,越来越多的研究表明炎症在心血管疾病中起着重要作用,其中全身免疫炎症指数可以更全面地反映全身炎症和局部免疫的平衡状况,对诸多心血管疾病的发生、发展和预后具有重要的预测价值。目前已有的研究表明,全身免疫炎症指数对多种心血管疾病的早期诊断有良好效果。本文重点对超声心动图及SII的联合运用进行综述,使其更好地应用于心衰的早期诊断。
Abstract: Heart failure is the leading cause of death from cardiovascular disease. Patients with stage C (symptomatic heart failure) and stage D (advanced heart failure) are faced with high mortality, repeated hospitalization, and poor treatment effect, so early diagnosis and early intervention are of great significance to effectively delay or prevent the occurrence and development of heart failure. At present, echocardiography is still the preferred cardiac imaging method for patients with heart failure. In terms of laboratory tests, more and more studies have shown that inflammation plays an important role in cardiovascular diseases, and the systemic immune inflammation index can more comprehensively reflect the balance of systemic inflammation and local immunity, which has important predictive value for the occurrence, development and prognosis of many cardiovascular diseases. At present, studies have shown that the systemic immune inflammatory index has a good effect on the early diagnosis of a variety of cardiovascular diseases. This article focuses on the combined use of echocardiography and SII to make it better used in the early diagnosis of heart failure.
文章引用:顾杨洋, 罗朋. 超声心动图联合全身免疫炎症指数对心力竭衰早期诊断的研究进展[J]. 临床医学进展, 2024, 14(11): 1502-1507. https://doi.org/10.12677/acm.2024.14113038

参考文献

[1] Wang, W., Hu, M., Liu, H., Zhang, X., Li, H., Zhou, F., et al. (2021) Global Burden of Disease Study 2019 Suggests That Metabolic Risk Factors Are the Leading Drivers of the Burden of Ischemic Heart Disease. Cell Metabolism, 33, 1943-1956.E2. [Google Scholar] [CrossRef] [PubMed]
[2] Cai, A., Qiu, W., Xia, S., Zhou, Y., Chen, J., Tan, N., et al. (2023) Sex-Specific Characteristics and Outcomes in Hospitalized Heart Failure with Preserved Ejection Fraction: The China Cardiovascular Association Database-Heart Failure Center Registry. European Heart Journal, 44, 4715-4718. [Google Scholar] [CrossRef] [PubMed]
[3] 中华医学会心血管病学分会, 中国医师协会心血管内科医师分会, 中国医师协会心力衰竭专业委员会, 等. 中国心力衰竭诊断和治疗指南2024 [J]. 中华心血管病杂志, 2024, 52(3): 235-275.
[4] 中国医师协会心力衰竭专业委员会, 国家心血管病专家委员会心力衰竭专业委员会, 中华心力衰竭和心肌病杂志编辑委员会. 心力衰竭生物标志物临床应用中国专家共识[J]. 中华心力衰竭和心肌病杂志, 2022, 6(3): 175-192.
[5] Souders, C.A., Bowers, S.L.K. and Baudino, T.A. (2009) Cardiac Fibroblast: The Renaissance Cell. Circulation Research, 105, 1164-1176. [Google Scholar] [CrossRef] [PubMed]
[6] Han, M., Liu, Z., Liu, L., Huang, X., Wang, H., Pu, W., et al. (2023) Dual Genetic Tracing Reveals a Unique Fibroblast Subpopulation Modulating Cardiac Fibrosis. Nature Genetics, 55, 665-678. [Google Scholar] [CrossRef] [PubMed]
[7] Kuppe, C., Ramirez Flores, R.O., Li, Z., Hayat, S., Levinson, R.T., Liao, X., et al. (2022) Spatial Multi-Omic Map of Human Myocardial Infarction. Nature, 608, 766-777. [Google Scholar] [CrossRef] [PubMed]
[8] 王晓龙, 崔兰. 急性心肌梗死相关炎症因子的研究进展[J]. 延边大学医学学报, 2018, 41(1): 58-60.
[9] 冯晔囡, 肖晗, 张幼怡. 自主神经系统调控心脏炎症反应的研究进展[J]. 生理学报, 2019, 71(2): 225-234.
[10] 朱国庆. NLRP3炎性小体激活与血管重构(英文) [C]//中国生理学会. 2019中国生理学会学术年会暨张锡钧基金第十五届全国青年优秀生理学学术论文交流会及第十三届全国青年生理学工作者学术会议论文摘要. 2019: 109-110.
[11] 潘奇峰. 超声心动图联合cTnl、NT-proBNP、D-二聚体在心血管急症诊断中的应用[J]. 中国医学物理学杂志, 2023, 40(5): 576-579.
[12] 吴贤涛, 陈凤慈, 黄利. 超声心动图联合血清脑钠肽检测对急性心肌梗死的早期诊断研究[J]. 影像研究与医学应用, 2020, 4(6): 216-218.
[13] 徐磊, 赵瑞平, 李洪宇, 等. 血浆microRNA联合超声心动图与急性心肌梗死诊断的相关性研究[J]. 齐齐哈尔医学院学报, 2023, 44(9): 801-807.
[14] 周允, 卢丽霞, 魏利龙, 等. 冠心病患者四种常规炎症标志物联合检测对急性心肌梗死的预测价值[J]. 中国动脉硬化杂志, 2023, 31(4): 297-303.
[15] 刘婷(综述), 吴铿(审校). 全身免疫炎症指数与心血管疾病相关性的研究进展[J]. 中国临床新医学, 2023, 16(6): 628-631.
[16] Hayıroğlu, M.İ., Çınar, T., Çinier, G., Pay, L., Yumurtaş, A.Ç., Tezen, O., et al. (2022) Evaluating Systemic Immune‐inflammation Index in Patients with Implantable Cardioverter Defibrillator for Heart Failure with Reduced Ejection Fraction. Pacing and Clinical Electrophysiology, 45, 188-195. [Google Scholar] [CrossRef] [PubMed]
[17] Liu, Y., Ye, T., Chen, L., Jin, T., Sheng, Y., Wu, G., et al. (2021) Systemic Immune-Inflammation Index Predicts the Severity of Coronary Stenosis in Patients with Coronary Heart Disease. Coronary Artery Disease, 32, 715-720. [Google Scholar] [CrossRef] [PubMed]
[18] Tang, Y., Zeng, X., Feng, Y., Chen, Q., Liu, Z., Luo, H., et al. (2022) Corrigendum: Association of Systemic Immune-Inflammation Index with Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study. Frontiers in Cardiovascular Medicine, 9, Article 1116547. [Google Scholar] [CrossRef] [PubMed]
[19] 安然, 秦璨, 武琼, 等. 全身免疫炎症指数对扩张型心肌病患者预后预测价值[J]. 临床军医杂志, 2022, 50(11): 1129-1133.
[20] 张豪, 周天, 马畅, 等. 新型炎症标志物对急性心肌梗死院内预后的预测价值[J]. 中国循环杂志, 2023, 38(4): 414-420.